“Appendix 3B New issue announcement, application for quotation of additional securities and agreement” has been released by Imagion Biosystems. Read Appendix 3B here.
Imagion Biosystems receives AU$3.5 million in R&D tax incentives
MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to report that it